Does good adherence to pharmacologic treatment guidelines improve clinical outcomes in outpatients with HFrEF?
Adherence to guideline-directed medical therapy at ≥50% of target doses is associated with improved short-term clinical outcomes in outpatients with HFrEF.
Good adherence to pharmacologic treatment guidelines for ACEIs, ARBs, BBs, MRAs and ivabradine, with prescription of at least 50% of recommended dosages, was associated with better clinical outcomes during 6-month follow-up. Continuing global educational initiatives are needed to emphasise the importance of guideline recommendations for optimising drug therapy and prescribing evidence-based doses in clinical practice.
Komajda et al. (Sun,) studied this question.